Navigation Links
Thoratec Schedules First Quarter 2008 Conference Call, Webcast
Date:4/25/2008

PLEASANTON, Calif., April 25 /PRNewswire-FirstCall/ -- Thoratec Corporation (Nasdaq: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today announced that it will report its operating results for the first fiscal quarter of 2008 on Thursday, May 1.

The company will hold a conference call to discuss its financial results and operating activities to all interested parties at 1:30 p.m., Pacific Daylight Time (4:30 p.m., Eastern Daylight Time), Thursday, May 1, hosted by Gary F. Burbach, president and chief executive officer, and David Smith, executive vice president and chief financial officer.

The teleconference can be accessed by calling (913) 981-5526, passcode 1224200. Please dial in 10-15 minutes prior to the beginning of the call. The webcast will also be available on the Internet at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=95989&eventID=1823004 or at http://www.thoratec.com.

A replay of the conference call will be available through Thursday, May 8, via http:///www.thoratec.com or by telephone at (719) 457-0820, passcode 1224200.

Thoratec Corporation is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies point-of-care blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com or http://www.itcmed.com


'/>"/>
SOURCE Thoratec Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Thoratec Announces Unanimous FDA Advisory Panel Recommendation for Approval of HeartMate II(R) for Bridge-to-Transplantation
2. URGENT Thoratec Corporation Worldwide Recall of Implantable Ventricular Assist Device
3. Thoratecs ITC Division Receives FDA Warning Letter
4. Thoratec Schedules Third Quarter Conference Call, Webcast
5. The Advisory Board Company Schedules Fourth Quarter Investor Conference Call for May 8, 2008
6. The Ensign Group Schedules 2008 First Quarter Earnings Call for Thursday, May 8, 2008
7. AMICAS Schedules First Quarter 2008 Earnings Call
8. Triple-S Management Corporation Schedules First-Quarter Earnings Release and Webcast
9. LeMaitre Vascular, Inc. Schedules First Quarter Results and Conference Call
10. Inverness Medical Innovations Schedules Conference Call for 10:00 a.m. ET April 24, 2008 to Discuss First Quarter 2008 Results
11. MSA Schedules First Quarter Earnings Webcast
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... ... 10 Best Water is excited to announce a new monthly ... topped the list as a result of their commitment to offering clients creative, customized, ... 5100, a top notch water company that specializes in providing the public with refreshing ...
(Date:2/10/2016)... ... February 10, 2016 , ... United Benefit Advisors (UBA), ... latest addition to its growing list of Partner Firms. S.S. Nesbitt is ... Orlando to Huntsville and in between. , Harnessing the experience and insights of ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... change in their patients. Research shows that the Goal Attainment Scale (GAS) captures ... overcome this challenge and learn more about the Goal Attainment Scale, Education Resources ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... revolutionary, biocompatible columns and accessories. These PEEK-lined stainless steel (PLS) columns combine the ... a solution that ensures the integrity of biological samples while operating at ultra-high ...
(Date:2/10/2016)... DC (PRWEB) , ... February 10, 2016 , ... Anxiety ... level since the start of Medicare Part D a decade ago, according to ... comments from older adults on how they are coping with rapidly rising costs. ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)...  Visage Imaging Inc. ("Visage"), a wholly owned ... that the American College of Radiology (ACR) and ... Visage 7 Enterprise Imaging Platform as the new ... SIMulation (SIM). SIM is the assessment component of ... multi-faceted and fully-integrated online assessment, education and remediation ...
(Date:2/10/2016)... Mast Therapeutics, Inc. (NYSE MKT: ... sickle cell disease and heart failure, today announced the ... at a price to the public of $0.275 per ... Company,s common stock and one warrant to purchase one ... price of $0.42 per share. The warrants are exercisable ...
(Date:2/10/2016)... New York , February 10, 2016 ... Growth, Trends and Forecast 2015 - 2023 ", reveals that ... rather slow growth from 2015 to 2023 owing to patent ... a meager CAGR of 1.30% during the forecast period, the ... to US$38.9 bn in 2023. --> Antibacterial Drugs ...
Breaking Medicine Technology: